S.A. Mason’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $218K | Buy |
8,999
+955
| +12% | +$23.1K | 0.11% | 169 |
|
|
2025
Q1 | $204K | Sell |
8,044
-287
| -3% | -$7.27K | 0.11% | 173 |
|
|
2024
Q4 | $221K | Buy |
8,331
+31
| +0.4% | +$822 | 0.12% | 162 |
|
|
2024
Q3 | $240K | Sell |
8,300
-117
| -1% | -$3.39K | 0.13% | 153 |
|
|
2024
Q2 | $236K | Buy |
8,417
+1,001
| +13% | +$28K | 0.13% | 146 |
|
|
2024
Q1 | $206K | Buy |
7,416
+30
| +0.4% | +$832 | 0.12% | 158 |
|
|
2023
Q4 | $213K | Sell |
7,386
-1,453
| -16% | -$41.8K | 0.14% | 145 |
|
|
2023
Q3 | $293K | Buy |
8,839
+89
| +1% | +$2.95K | 0.21% | 117 |
|
|
2023
Q2 | $357K | Hold |
8,750
| – | – | 0.26% | 105 |
|
|
2023
Q1 | $357K | Sell |
8,750
-275
| -3% | -$11.2K | 0.26% | 105 |
|
|
2022
Q4 | $462K | Buy |
9,025
+14
| +0.2% | +$717 | 0.35% | 82 |
|
|
2022
Q3 | $394K | Buy |
9,011
+14
| +0.2% | +$612 | 0.31% | 90 |
|
|
2022
Q2 | $472K | Sell |
8,997
-173
| -2% | -$9.08K | 0.34% | 82 |
|
|
2022
Q1 | $475K | Sell |
9,170
-136
| -1% | -$7.05K | 0.3% | 92 |
|
|
2021
Q4 | $550K | Buy |
9,306
+13
| +0.1% | +$768 | 0.33% | 84 |
|
|
2021
Q3 | $400K | Buy |
9,293
+1,230
| +15% | +$52.9K | 0.26% | 104 |
|
|
2021
Q2 | $316K | Buy |
8,063
+5
| +0.1% | +$196 | 0.22% | 124 |
|
|
2021
Q1 | $292K | Buy |
8,058
+4
| +0% | +$145 | 0.22% | 120 |
|
|
2020
Q4 | $296K | Sell |
8,054
-146
| -2% | -$5.37K | 0.25% | 108 |
|
|
2020
Q3 | $286K | Sell |
8,200
-3
| -0% | -$105 | 0.27% | 98 |
|
|
2020
Q2 | $255K | Sell |
8,203
-362
| -4% | -$11.3K | 0.27% | 101 |
|
|
2020
Q1 | $265K | Sell |
8,565
-276
| -3% | -$8.54K | 0.32% | 90 |
|
|
2019
Q4 | $329K | Buy |
+8,841
| New | +$329K | 0.31% | 95 |
|